Patient insight is key to a successful solution. The wearable technology market has come of age, with the emergence of wearables into the consumer mainstream. Products like Apple Watch and Fitbit have set the stage for an acceptance of products that are more focused around specific health outcomes.
The wearable technology market has come of age, with the emergence of
wearables into the consumer mainstream. Products like Apple Watch and Fitbit
have set the stage for an acceptance of products that are more focused around
specific health outcomes.
Pharmaceutical companies seeking to support patients “beyond the pill”
are excited by this opportunity. The wearables market is projected to be
worth $25bn by 2019 – so adopting the most effective approach to product
development will be critical for maximising returns. Companies must also consider
the effect of the wearable technology on the patient and whether it might meet
the definition of a regulated medical device.
If more than a decade’s experience in developing digital patient
engagement for pharmaceutical companies has taught us anything, it’s that
bringing patients into the development process is a fundamental part of a
successful project.
Whatever the product, whether it’s a device for blood analysis or an app
to promote healthy living, it’s important to engage with potential users as
early as possible in the development process, to understand who they are, their
environment, their routine, habits and drivers. These are foundational insights
which technologists neglect at their peril.
Glynn Godwin, our
VP Interactive & Design, shares his thoughts on the wearable technology
market with Pharma Market Europe here
Project Manager uses personal development funding to support friends' and colleagues' well-being – by Helen Capelin Head of Operational Excellence. Ashfield
We are happy to announce that we have officially moved into our Manchester office! This will be our 16th office for Ashfield Healthcare Communications along with our others across Europe, America, and Asia-Pacific. Ashfield
Client Relationship Director Fabienne Wild from Ashfield Meetings & Events reflects on the recent conference season and on her experience at the European Society for Medical Oncology (ESMO). Ashfield
Today's healthcare companies are looking for an agile and responsive partner to help them overcome complex challenges, deliver innovative products and break into new markets. Ashfield
Ashfield Healthcare Communications, a leading global healthcare communications agency, today welcomes its third intake of aspiring medical writers into its accelerated medical writing training programme, Allegro. Ashfield